Close

Drug Research

AI in Alzheimer Drug Development to Enhances Clinical Trials

Scientists applied artificial intelligence (AI) to reanalyse a clinical trial for AI in Alzheimer Drug Development, identifying a group of patients who responded to medical...

Merck to Initiate Phase 3 Trials for Investigational Once-Monthly...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the initiation of the EXPrESSIVE Phase 3 clinical trials, evaluating...

China Unveils Innovative Drugs Policy to Boost Development

The National Health Commission and China's National Healthcare Security Administration (NHSA) together unveiled a comprehensive new policy on June 30 called "Several Measures to Support...

Hikma Pharmaceuticals USA announces $1 Billion of new US...

London, 28 June 2025 – In its ongoing mission to help meet America’s growing need for high-quality US-made medicines, Hikma Pharmaceuticals USA today announces it...

Biopharma Production with AI: A New Era in Manufacturing

A New Era of Biopharma Production with AI The biopharma industry is undergoing a transformation as it capitalises on the potential of artificial intelligence (AI) to...

AI Drug Discovery Transforming APAC Biopharma Innovation

The Asia-Pacific (APAC) biopharmaceutical space is being revolutionized by the tremendous progress made in artificial intelligence (AI). The use of AI technologies to drive drug...

Projected Growth of Injectable Drug Market To $1139B By...

According to a recent analysis released by MarketsandMarkets, the injectable medication delivery market is expected to grow at a compound annual growth rate (CAGR) of...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read